Fireman B.V. IPO Research Information

Fireman B.V. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Fireman B.V., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Fireman B.V.	IFRX - NASDAQ	$14.00-$16.00	$15.00	$15.19	6.67 million	11/8/2017
Underwriter(s): J.P. Morgan, Leerink Partners, BMO Capital Markets
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2017-10-13 Terms Added 2017-10-30 Final Prospectus 2017-11-08

Fireman B.V. Quote & Chart - Click for current quote - IFRX

About Fireman B.V. (adapted from Fireman B.V. prospectus):
They are a clinical stage biopharmaceutical company focused on applying their proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "IFRX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.